{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T01:59:46Z","timestamp":1780451986036,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,2]],"date-time":"2026-12-02T00:00:00Z","timestamp":1796169600000},"content-version":"am","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.dmpk.2025.101504","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T07:25:06Z","timestamp":1758785106000},"page":"101504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A novel quantitative assessment of formed reactive metabolites by double trapping with [3H]glutathione and [14C]cyanide"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4702-7481","authenticated-orcid":false,"given":"Tomoyuki","family":"Kawachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2416-5988","authenticated-orcid":false,"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.dmpk.2025.101504_bib1","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/clpt.2011.63","article-title":"Drug safety sciences and the bottleneck in drug development","volume":"89","author":"Watkins","year":"2011","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101504_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.2174\/1574886314666191004092520","article-title":"Drug withdrawal due to safety: a review of the data supporting withdrawal decision","volume":"15","author":"Craveiro","year":"2020","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.dmpk.2025.101504_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9737920","article-title":"Key challenges and opportunities associated with the use of in vitro models to detect human Dili: integrated risk assessment and mitigation plans","author":"Atienzar","year":"2016","journal-title":"BioMed Res Int"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101504_bib4","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cpt.564","article-title":"Drug-induced liver injury: advances in mechanistic understanding that will inform risk management","volume":"101","author":"Mosedale","year":"2017","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101504_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1021\/acs.chemrestox.6b00357","article-title":"How reactive metabolites induce an immune response that sometimes leads to an idiosyncratic drug reaction","volume":"30","author":"Cho","year":"2017","journal-title":"Chem Res Toxicol"},{"issue":"8","key":"10.1016\/j.dmpk.2025.101504_bib6","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1517\/17425255.2015.1048222","article-title":"Detecting reactive drug metabolites for reducing the potential for drug toxicity","volume":"11","author":"Grillo","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101504_bib7","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1021\/tx0496791","article-title":"Dansyl glutathione as a trapping agent for the quantitative estimation and identification of reactive metabolites","volume":"18","author":"Gan","year":"2005","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101504_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2133\/dmpk.24.100","article-title":"Quantitative assessment of reactive metabolite formation using 35S-labeled glutathione","volume":"24","author":"Takakusa","year":"2009","journal-title":"Drug Metabol Pharmacokinet"},{"issue":"10","key":"10.1016\/j.dmpk.2025.101504_bib9","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1021\/tx0501637","article-title":"Cyanide trapping of iminium ion reactive intermediates followed by detection and structure identification using liquid chromatography-tandem mass spectrometry (LC-MS\/MS)","volume":"18","author":"Argoti","year":"2005","journal-title":"Chem Res Toxicol"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101504_bib10","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.drudis.2016.11.018","article-title":"Minimizing the risk of chemically reactive metabolite formation of new drug candidates: implications for preclinical drug design","volume":"22","author":"Brink","year":"2017","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101504_bib11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2133\/dmpk.24.245","article-title":"A trapping method for semi-quantitative assessment of reactive metabolite formation using 35S cysteine and 14C cyanide","volume":"24","author":"Inoue","year":"2009","journal-title":"Drug Metabol Pharmacokinet"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101504_bib12","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1124\/dmd.109.028860","article-title":"Evaluation of the potential for drug-induced liver injury based on in vitro covalent binding to human liver proteins","volume":"37","author":"Usui","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"10.1016\/j.dmpk.2025.101504_bib13","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1124\/dmd.109.027797","article-title":"A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding","volume":"37","author":"Nakayama","year":"2009","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101504_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1517\/17425255.1.1.91","article-title":"Minimising the potential for metabolic activation in drug discovery","volume":"1","author":"Kalgutkar","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101504_bib15","article-title":"Asymptomatic hepatitis as a late side effect of clozapine: a case report","volume":"2","author":"Lucas","year":"2023","journal-title":"Psychiatr Res Case Rep"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101504_bib16","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1002\/ccr3.3324","article-title":"Clopidogrel-induced liver damage: a case report and review of the literature","volume":"8","author":"Eslami","year":"2020","journal-title":"Clin Case Rep"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101504_bib17","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1176\/appi.ajp.2013.13050709","article-title":"Antidepressant-induced liver injury: a review for clinicians","volume":"171","author":"Voican","year":"2014","journal-title":"Am J Psychiatr"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101504_bib18","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1124\/dmd.31.12.1499","article-title":"Acetaminophen-induced hepatotoxicity","volume":"31","author":"James","year":"2003","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101504_bib19","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1124\/dmd.104.002683","article-title":"Metabolic activation of pioglitazone identified from rat and human liver microsomes and freshly isolated hepatocytes","volume":"33","author":"Baughman","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"10.1016\/j.dmpk.2025.101504_bib20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1124\/dmd.104.002840","article-title":"Identification of a novel glutathione adduct of diclofenac, 4\u2032-hydroxy-2\u2032-glutathion-deschloro-diclofenac, upon incubation with human liver microsomes","volume":"33","author":"Yu","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101504_bib21","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1124\/dmd.105.006866","article-title":"Human in vitro glutathionyl and protein adducts of carbamazepine-10,11- epoxide, a stable and pharmacologically active metabolite of carbamazepine","volume":"33","author":"Bu","year":"2005","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"10.1016\/j.dmpk.2025.101504_bib22","doi-asserted-by":"crossref","DOI":"10.1021\/tx8004828","article-title":"Metabolie oxidative cleavage of thioesters: evidence for the formation of sulfenic acid intermediates in the bioactivation of the antithrombotic prodrugs ticlopidine and clopidogrel","volume":"22","author":"Dansette","year":"2009","journal-title":"Chem Res Toxicol"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101504_bib23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/rcm.3953","article-title":"Rapid detection and characterization of reactive drug metabolites in vitro using several isotope-labeled trapping agents and ultra-performance liquid chromatography\/time-of-flight mass spectrometry","volume":"23","author":"Rousu","year":"2009","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"11","key":"10.1016\/j.dmpk.2025.101504_bib24","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1021\/tx700132x","article-title":"NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine","volume":"20","author":"Zhao","year":"2007","journal-title":"Chem Res Toxicol"},{"issue":"1\u20132","key":"10.1016\/j.dmpk.2025.101504_bib25","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1432-1033.1997.0452a.x","article-title":"Expression and intracellular localization of catechol O-methyltransferase in transfected mammalian cells","volume":"243","author":"Ulmanen","year":"1997","journal-title":"Eur J Biochem"},{"issue":"12","key":"10.1016\/j.dmpk.2025.101504_bib26","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1124\/dmd.111.040469","article-title":"Involvement of different human glutathione transferase isoforms in the glutathione conjugation of reactive metabolites of troglitazone","volume":"39","author":"Okada","year":"2011","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"10.1016\/j.dmpk.2025.101504_bib27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.2131\/jts.44.201","article-title":"Novel risk assessment of reactive metabolites from discovery to clinical stage","volume":"44","author":"Kakutani","year":"2019","journal-title":"J Toxicol Sci"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101504_bib28","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1124\/mol.111.073783","article-title":"Mechanism-based inactivation of human cytochrome P450 2B6 by clopidogrel: involvement of both covalent modification of cysteinyl residue 475 and loss of heme","volume":"80","author":"Zhang","year":"2011","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.dmpk.2025.101504_bib29","doi-asserted-by":"crossref","unstructured":"Dragovic S, Gunness P, Ingelman-Sundberg M, Vermeulen NPE, Commandeur JNM., Characterization of human cytochrome P450s involved in the bioactivation of clozapines., Drug Metab Dispos ;41(3):651-658, DOI:10.1124\/dmd.112.050484.","DOI":"10.1124\/dmd.112.050484"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101504_bib30","doi-asserted-by":"crossref","DOI":"10.1124\/dmd.108.020545","article-title":"Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug","volume":"36","author":"Bauman","year":"2008","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.dmpk.2025.101504_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1021\/tx980249i","article-title":"New concepts in immunology relevant to idiosyncratic drug reactions: the 'danger hypothesis' and innate immune system","volume":"12","author":"Uetrecht","year":"1999","journal-title":"Chem Res Toxicol"},{"issue":"1","key":"10.1016\/j.dmpk.2025.101504_bib32","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1021\/bi00167a022","article-title":"Thiophene derivatives as new mechanism-based inhibitors of cytochromes P-450: inactivation of yeast-expressed human liver cytochrome P-450 2C9 by tienilic acid","volume":"33","author":"L\u00f3pez-Garcia","year":"1994","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.dmpk.2025.101504_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1124\/mol.114.094862","article-title":"Characterization of ritonavir-mediated inactivation of cytochrome P450 3A4","volume":"86","author":"Rock","year":"2014","journal-title":"Mol Pharmacol"},{"issue":"7","key":"10.1016\/j.dmpk.2025.101504_bib34","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1124\/dmd.111.039180","article-title":"Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites","volume":"39","author":"Nakayama","year":"2011","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436725004549?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436725004549?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T10:15:12Z","timestamp":1770804912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436725004549"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":34,"alternative-id":["S1347436725004549"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2025.101504","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel quantitative assessment of formed reactive metabolites by double trapping with [3H]glutathione and [14C]cyanide","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2025.101504","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101504"}}